From QuestDiagnostics: MADISON, N.J.,March 23, 2015/PRNewswire/ People in states that expanded Medicaid under the Affordable Care Act (ACA) are far more likely to be newly identified with diabetes than in states that elected not to expand the public health care program, finds a new study by researchers atQuest Diagnostics(NYSE:DGX). Published online today inDiabetes Care, the […]
Category: The issues (Page 3)
Source:http://www.npr.org/blogs/health/2015/03/19/393856788/why-is-u-s-insulin-so-expensive Why Is Insulin So Expensive In The U.S.? Dr. Jeremy Greene sees a lot of patients with diabetes thats out of control. In fact, he says, sometimes their blood sugar is so high that you cant even record the number on their glucometer. Greene, a professor of medicine and history of medicine at Johns […]
From ADA:http://diabetesstopshere.org/2015/03/18/erins-story/ ADAs blog, the Your Rights, One Voice blog features about diabetes discrimination and how the American Diabetes Association helps through Legal Advocacy. This month ADAs Your Rights, One Voice story profiles, Erin Argueta, an experienced traveler who has type 1 diabetes. When Erin had to travel for business, she needed to leave earlier […]
JDRFhas an advocacy action open to anyone interested Ensure Seniors with Diabetes have Access to Continuous Glucose Monitors. Legislation has been introduced to the House; a Senate bill is expected soon.JDRFmakes it easy for individualsto contact theirCongress Member through a letter generation form. JDRFscall to actionsays: Urge Your Representative to Co-sponsor H.R. 5644 to Ensure […]
ADA has an advocacy action open to anyone interested in supporting theSpecial Diabetes Program andChildrens Health Insurance Program (CHIP).ADAmakes it easy for individualsto contact their Congress Member and Senators through a letter generation form. ADAs call to action says: Congress is about to vote on two critical diabetes programs in the coming days. Will you […]
Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System Amulti-center, prospective, non-pivotal, single arm, non-significant risk evaluation the Abbott Sensor Based Glucose Monitoring System Pro across different stages of T2 diabetes management. This is a non-significant risk study.Locations in: California, Michigan, Missouri, North Carolina & Texas Detailed Description: Subjects will wear two […]
Please share the AMA & CDC InitiativePrevent Diabetes STAT Particularly this tool Kit:http://www.ama-assn.org/sub/prevent-diabetes-stat/toolkit.html With more than 86 million Americans living with prediabetes and nearly 90 percent of them unaware of it, the American Medical Association (AMA) and the Centers for Disease Control and Prevention (CDC) today announced that they have joined forces to take urgent […]
Insulin Pumps Need Greater Safety Review: American Diabetes Association Issues Joint Statement with European Association for the Study of Diabetes Alexandria, Virginia March16,2015 Not enough is known about the safety and efficacy of insulin pumps, and a comprehensive safety overhaul including greater access to data from pump manufacturers and public funding of research on the […]
Smart Insulin (MK-2640) Starts A Clinical Trial But the big news is that Smart Insulin has started clinical (human) trials. In fact, the trial started months ago, in November 2014. I missed it, mostly because Merck changed the drugs name from Smart Insulin to L-490 to MK-2640. The clinical trial was under the name MK-2640, […]
See:https://www.eventbrite.com/e/webinar-the-fda-docket-tickets-15695602971 The FDA Office of Minority Health (OMH) will host a webinar to share with you how and why to comment to a docketa public record of information about an FDA action. When you comment, your voice is formally on record. Date:Wednesday, March 25, 2015 Time:2:00 3:00 PM ET RSVP:12:00 PM, Monday, March 23, 2015 […]